Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
5.30
-0.09 (-1.67%)
Nov 13, 2026, 3:00 PM CST

SHA:605199 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-421.71-287.37-274.4610.8585.6872.14
Depreciation & Amortization
97.4998.7377.8258.8851.0348.17
Other Amortization
3.922.681.630.830.540.31
Loss (Gain) From Sale of Assets
0.050.05-0.040.080.010.09
Asset Writedown & Restructuring Costs
12.7412.740.86-0.541.83
Loss (Gain) From Sale of Investments
2.952.95-8.18-0.35-0.55-0.32
Provision & Write-off of Bad Debts
23.5823.584.0915.58-0.233.23
Other Operating Activities
265.7364.8244.4333.3522.8912.65
Change in Accounts Receivable
-50.56-50.5617.8-63.98-245.05-34.15
Change in Inventory
163.83163.83-173.06-74.9-6.06-28.79
Change in Accounts Payable
102.74102.74165.4248.19326.920.38
Change in Other Net Operating Assets
-0.08-0.08----
Operating Cash Flow
203.43136.85-149.1228.25238.71102.48
Operating Cash Flow Growth
78.01%---88.17%132.93%3005.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.2-83.67-156.23-489.2-392.32-137.62
Sale of Property, Plant & Equipment
0.020.010.070.080.260.11
Cash Acquisitions
----35.1--
Divestitures
--13.68---
Investment in Securities
-----19.540.11
Investing Cash Flow
-22.18-83.66-142.48-524.21-411.6-117.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-592.9735.741,140686.02464.22
Long-Term Debt Repaid
--800.59-620.52-552.39-507.52-260.53
Lease Payments
-80.61-20.55-3.66-6.77-5.73-3.72
Net Debt Issued (Repaid)
-162.96-207.69115.22588.08178.5203.68
Common Dividends Paid
-27.78-33.55-92.16-31.56-14.35-73.75
Other Financing Activities
-53.6--1.23-3.47-16.38
Financing Cash Flow
-244.34-241.2521.83553.06164.15146.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-63.09-188.05-269.7757.1-8.74131.7

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
181.2353.18-305.35-460.95-153.61-35.14
Free Cash Flow Growth
519.31%-----
Free Cash Flow Margin
29.59%5.90%-21.60%-25.68%-10.14%-2.60%
Free Cash Flow Per Share
0.450.13-0.77-1.27-0.38-0.09
Levered Free Cash Flow
511.597.51-188.22-516.59-206.31-52.48
Unlevered Free Cash Flow
518.2122.97-168.37-505.19-195.06-43.81
Free Cash Flow After Leases
100.6232.63-309.01-467.71-159.35-38.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
44.0891.14147.75133.28138.47124.58
Change in Working Capital
218.67218.674.73-90.9878.81-35.62